en · de · es · fr · pt
cjc-1295-notes.peptides6908.com › Data › Cjc-1295 Structure And Mechanism — What the Evidence Shows

Cjc-1295 Structure And Mechanism — What the Evidence Shows

By Editorial Desk · published 2025-12-07 · last reviewed 2025-12-22 · Data

Drug affinity complex is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2025-12-22. Numbers and descriptions here follow the published literature rather than marketing material.

CJC-1295 Structure And Mechanism

Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.

The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.

Compound Identity and Development History

The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.

Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.

Cjc-1295 at a glance

PropertyValueNotes
Physical formLyophilized white powderSupplied as a freeze-dried solid for research use
Molecular weightApproximately 3,647 Da (DAC form)Lower for the variant lacking the albumin-binding moiety
SolubilitySoluble in water and aqueous bufferTypically dissolved in sterile or bacteriostatic water
Typical storage temperature−20 °C or belowDry powder, desiccated and protected from light
Common analytical methodReversed-phase HPLC with mass spectrometryUsed for purity estimation and identity confirmation

Background and Molecular Design

CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.

Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.

Related pages on this site

Analytical Characterization and Storage

Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.

Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.

Notes from published material

Metal tagged antibodies however are viable for up to two weeks without losing signal, adding more flexibility to experiments. The stained samples can also be cryopreserved, which may be particularly useful for clinical trials when samples are collected over a longer period of time. Costs of CyTOF are high, as the metal-tagged antibodies and antibody conjunction kits are expensive. A major downside of CyTOF is that acquisition flow rate is quite slow compared to flow cytometry, by almost an order of magnitude. Because heavy metals are common in laboratory reagents, avoiding contamination during sample preparation is very important.

In a June 2024 article in The Diplomat, University of Bonn (Germany) professor Maximilian Mayer and Jagiellonian University (Poland) professor Emilian Kavalski opined that the China–Russia relations have been stronger than before and that Xi's China will "fully back Putin's effort to threaten and undermine liberal democratic states", threatening European security and dashing any hopes that the relations between the two countries would become further strained. Mayer and Kavalski criticised Europe for lacking "historical templates" and its "tripartite approach to China—as [its] partner, competitor, and rival" as "woefully outdated because it [the approach] lacks a security angle altogether". Both the professors further advised Europe to address China's strong ties with and strong support for Russia's further aggressive plans toward Europe.

=== Joel Graham === Joel Graham (Sam Jaeger) is Julia's husband and Sydney and Victor's father. He is a stay-at-home father, and is popular among the stay-at-home mothers in their social circle at Sydney's school, a fact which sometimes puts strains on his marriage. He is shown to be very capable domestically and hosts a regular playdate that is very popular. Though he's 100% committed to the job of raising his daughter, he sometimes finds himself starved for adult interaction. He is a licensed contractor and he and Julia agreed that he would stay home with Sydney after he couldn't afford to keep paying his crew. In season two, it is revealed that his mother died when he was younger, something that affects his faith and belief in an afterlife. In the season finale of season 3, Julia and Joel adopt a young boy named Victor. In season 4, Julia becomes a stay-at-home mom while Joel returns to work as a contractor. In season 5, Joel moves into his own apartment because he can't cope with her emotional affair with Ed, a parent Julia volunteers with at the school, which leads to him kissing her. It is also revealed during their separation that his father cheated on his mother, which may be the reason why Julia's behavior is affecting him so much. In the final season, Joel and Julia are able to mend their broken relationship and adopt Victor baby sister. Soon after, it is revealed that Julia has given birth to a son.

== Low gravity == It has been observed that being in Earth's orbit has an effect on the structure of spider webs in space. Spider webs were spun in low Earth orbit in 1973 aboard Skylab, involving two female European garden spiders (cross spiders) called Arabella and Anita, as part of an experiment on the Skylab 3 mission. The aim of the experiment was to test whether the two spiders would spin webs in space, and, if so, whether these webs would be the same as those that spiders produced on Earth. The experiment was a student project of Judy Miles of Lexington, Massachusetts. After the launch on July 28, 1973, and entering Skylab, the spiders were released by astronaut Owen Garriott into a box that resembled a window frame. The spiders proceeded to construct their web while a camera took photographs and examined the spiders' behavior in a zero-gravity environment. Both spiders took a long time to adapt to their weightless existence. However, after a day, Arabella spun the first web in the experimental cage, although it was initially incomplete.

Sources: en.wikipedia.org

Background from the literature

==== Trump impeachment ==== After Dingell voted to impeach President Donald Trump, Trump attacked Dingell during a campaign rally in Battle Creek, musing that her late husband might be in hell, saying of him, "Maybe he's looking up, I don't know, I don't know, maybe, maybe. But let's assume he's looking down." She was attending a bipartisan Problem Solvers Caucus gathering when she was told of Trump's remarks. Numerous members of both parties came to Dingell's defense. In her response to the incident, Dingell called for a return to civility, saying, "some things should be off limits." In her 2022 book Confidence Man, New York Times reporter Maggie Haberman wrote that Dingell received a call from a man claiming to be a reporter who asked whether she was "looking for an apology from Trump". According to Haberman, "Dingell couldn't shake the idea that his voice sounded like that of the forty-fifth president." On June 24, 2025, Dingell was one of 128 House Democrats who voted against an impeachment resolution against President Trump over the June 21 U.S attack on Iran's nuclear sites.

== Biosynthetic pathway == Aflatoxin B1 is derived from both a dedicated fatty acid synthase (FAS) and a polyketide synthase (PKS), together known as norsolorinic acid synthase. The biosynthesis begins with the synthesis of hexanoate by the FAS, which then becomes the starter unit for the iterative type I PKS. The PKS adds seven malonyl-CoA extenders to the hexanoate to form the C20 polyketide compound. The PKS folds the polyketide in a particular way to induce cyclization to form the anthraquinone norsolorinic acid. A reductase then catalyzes the reduction of the ketone on the norsolorinic acid side-chain to yield averantin. Averantin is converted to averufin via a two different enzymes, a hydroxylase and an alcohol dehydrogenase. This will oxygenate and cyclize averantin's side chain to form the ketal in averufin. From this point on the biosynthetic pathway of aflatoxin B1 becomes much more complicated, with several major skeletal changes. Most of the enzymes have not been characterized and there may be several more intermediates that are still unknown. However, what is known is that averufin is oxidized by a P450-oxidase, AvfA, in a Baeyer-Villiger oxidation. This opens the ether rings and upon rearrangement versiconal acetate is formed. Now an esterase, EstA, catalyzes the hydrolysis of the acetyl, forming the primary alcohol in versiconal. The acetal in versicolorin A is formed from the cyclization of the side-chain in versiconal, which is catalyzed by VERB synthase, and then VerB, a desaturase, reduces versicolorin B to form the dihydrobisfuran.

== Society == In March 2013, there was media coverage of a British 7-year-old boy named Owen, with chronically tense muscles due to SJS, and his three-legged pet dog. They became first-place winners of the 2013 Crufts Kennel Club's annual Friends for Life competition, which "celebrates dogs that have truly earned the title of man’s best friend through bravery, support or companionship". The dog was also awarded The Braveheart Honour in the ceremony of The British Animal Honours in April 2013 (Haatchi the dog). The two are featured in the book Haatchi & Little B (2014, ISBN 125-006-936-X) by Wendy Holden and on Haatchi's Facebook page. In 2016, 9-year-old Owen was featured in a TLC documentary series, Two in a Million, in which he met and formed a friendship with Giovanni, a 7-year-old American boy with SJS.

Since this went too far for the Centre's national leadership, the negotiations were transferred to the national level, where Heinrich Brüning conferred with Gregor Strasser. During that period the anti-Nazi polemics ceased in order not to disturb the negotiations. Since the NSDAP was the larger party, the Centre was willing to accept a Nazi as Chancellor, provided he could gain the trust of the President, which at that time seemed quite a difficult task. The negotiations were bound for failure, since the aims of the two groups were largely incompatible. The Centre argued that the vote of July had "called Hitler not to dictatorship but to responsibility, to getting in line with law and constitution". They hoped to "build a strong government without touching the substance of the constitution", to create "clear responsibilities" and to "preclude anti-constitutional experiments". The Centre advocated a return to Brüning's "authoritarian democracy", which they considered up to the times and tested by experience, against Papen's "omnipotent state and independent leadership", while the Nazis would only accept a coalition that would serve their purpose of achieving total dominance. Not expecting a successful conclusion, Hitler used the Centre negotiations in order to put pressure on the Papen administration. The negotiations were also met with criticism from within the Centre Party. Some rejected them as "currying favour with the National Socialists" and giving credence to Hitler's strategy of legality.

== Clinical importance == S. haemolyticus is the second-most clinically isolated CoNS (S. epidermidis is the first) and it is considered an important nosocomial pathogen. Human infections include: native valve endocarditis, sepsis, peritonitis, and urinary tract, wound, bone, and joint infections. Infrequent soft-tissue infections usually occur in immunocompromised patients. Like other CoNS, S. haemolyticus is often associated with the insertion of foreign bodies, such as prosthetic valves, cerebrospinal fluid shunts, orthopedic prostheses, and intravascular, urinary, and dialysis catheters. S. haemolyticus is multi-drug resistant and able to form biofilms, which makes infections especially difficult to treat.

Sources: en.wikipedia.org

Frequently asked questions

How does CJC-1295 differ from modified GRF(1-29)?

The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.

Is CJC-1295 an approved medicine?

It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.

What is known about its half-life?

Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.

What is CJC-1295?

It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.

Network